Tag: US Securities and Exchange Commission
ASX-listed Telix Pharmaceuticals unveils potential plan for US listing
Melbourne-based biopharmaceutical giant Telix Pharmaceuticals announced today its plans for an initial public offering in the United States and listing on the Nasdaq Global...
Amcor’s move to acquire Bemis edges closer to completion
Amcor has announced that it has made significant progress towards completing the $5.25 billion, all-stock transaction to acquire US company Bemis.
The transaction has already...